| Literature DB >> 36136132 |
Ben J M Hermans1, Vanessa Weberndörfer1,2, Geertruida P Bijvoet1,2, Sevasti-Maria Chaldoupi2, Dominik Linz3,4,5,6,7.
Abstract
The current classification of atrial fibrillation (AF) is mainly focused on the clinical presentation according to the duration of AF episodes and the mode of termination, which incompletely reflect the severity and progressive nature of the underlying atrial disease. In this review article, "atrial cardiomyopathy" is discussed as a new concept in AF pathophysiology. Electrogram-, imaging-, and biomarker-derived measures and parameters to assess atrial cardiomyopathy, which will likely impact how AF is clinically classified and managed in the future, are presented.Entities:
Keywords: Atrial cardiomyopathy; Atrial fibrillation pathophysiology; Biomarkers; Electrogram; Imaging
Year: 2022 PMID: 36136132 DOI: 10.1007/s00399-022-00897-1
Source DB: PubMed Journal: Herzschrittmacherther Elektrophysiol ISSN: 0938-7412